Sean Ainsworth is the founder of Immusoft. Immusoft has raised $20M in total funding. Latest round: Series B.
Sean Ainsworth is the Chief Executive Officer and Chairman of the Board at Immusoft. He has 20 years of experience in pharmaceuticals and biotechnology. Previously, he founded RetroSense Therapeutics, a gene therapy company that he led into human clinical trials and sold to Allergan in 2016.
Full founder directory · Investor directory · Company funding database · Fundraising library